1. Home
  2. IDE vs GNFT Comparison

IDE vs GNFT Comparison

Compare IDE & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDE
  • GNFT
  • Stock Information
  • Founded
  • IDE 2010
  • GNFT 1999
  • Country
  • IDE United States
  • GNFT France
  • Employees
  • IDE N/A
  • GNFT N/A
  • Industry
  • IDE Finance/Investors Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IDE Finance
  • GNFT Health Care
  • Exchange
  • IDE Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • IDE 186.0M
  • GNFT 216.7M
  • IPO Year
  • IDE N/A
  • GNFT 2019
  • Fundamental
  • Price
  • IDE $12.37
  • GNFT $4.14
  • Analyst Decision
  • IDE
  • GNFT Strong Buy
  • Analyst Count
  • IDE 0
  • GNFT 2
  • Target Price
  • IDE N/A
  • GNFT $10.00
  • AVG Volume (30 Days)
  • IDE 33.5K
  • GNFT 5.0K
  • Earning Date
  • IDE 01-01-0001
  • GNFT 09-22-2025
  • Dividend Yield
  • IDE 8.83%
  • GNFT N/A
  • EPS Growth
  • IDE N/A
  • GNFT N/A
  • EPS
  • IDE N/A
  • GNFT N/A
  • Revenue
  • IDE N/A
  • GNFT $52,994,715.00
  • Revenue This Year
  • IDE N/A
  • GNFT $3.14
  • Revenue Next Year
  • IDE N/A
  • GNFT N/A
  • P/E Ratio
  • IDE N/A
  • GNFT N/A
  • Revenue Growth
  • IDE N/A
  • GNFT N/A
  • 52 Week Low
  • IDE $8.61
  • GNFT $2.55
  • 52 Week High
  • IDE $10.46
  • GNFT $6.03
  • Technical
  • Relative Strength Index (RSI)
  • IDE 57.61
  • GNFT 49.76
  • Support Level
  • IDE $12.18
  • GNFT $4.07
  • Resistance Level
  • IDE $12.40
  • GNFT $4.24
  • Average True Range (ATR)
  • IDE 0.14
  • GNFT 0.14
  • MACD
  • IDE 0.03
  • GNFT -0.01
  • Stochastic Oscillator
  • IDE 94.23
  • GNFT 41.70

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: